Keyword: Biogen

News

Forward Pharma Loses Patent Appeal Against Biogen

31.10.2018 - A US federal appeals court has rejected an appeal by Danish biopharma Forward Pharma against the validity of Biogen’s patent for blockbuster multiple sclerosis (MS) drug Tecfidera...

News

Sanofi May Move Rare Disease to Boston Area

22.10.2018 - French drugmaker Sanofi is planning to deepen the rare diseases footprint of its Genzyme franchise at Cambridge, Massachusetts, US, where according to reports the business could...

News

Biogen/Samsung Bioepis End Patent Dispute with AbbVie

10.04.2018 - Biogen and partner Samsung Bioepis have reached agreement with AbbVie regarding the commercialization of Imraldi, their biosimilar form of the latter’s blockbuster Humira. Specific...

News

Biogen Licenses Remedy’s Stroke Drug

19.05.2017 - Biogen has licensed a late-stage stroke drug from Remedy Pharmaceuticals. The US biotech will make an upfront payment of $120 million for Cirara (intravenous glyburide), as well as...

News

Biogen Alzheimer’s Drug Accepted for EMA PRIME

03.06.2016 - Biogen’s investigational treatment for early Alzheimer’s disease (AD), aducanumab, has been accepted into the European Medicines Agency’s (EMA) PRIority MEdicines (PRIME) program...

News

Biogen to Spin off Hemophilia business

20.05.2016 - US biotechnology company Biogen is to spin off its hemophilia business into an independent, publicly traded business. Biogen said it believes the creation of two separate companies...

News

Pharma Majors Join Parkinson’s Initiative

24.02.2016 - Major drugs firms AstraZeneca, Pfizer and Eli Lilly are among seven of the world’s largest pharmaceutical companies that have joined a new consortium to improve clinical trials for...

News

Biogen to Cut Staff, Focus on Oral MS Drug

27.10.2015 - Biogen has announced a corporate restructuring scheme that will lead it to terminate a number of drug pipeline programs while cutting the workforce by 11% up to the end of this...